Search Results - "Ortiz Canseco, Julio"
-
1
MmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212
Published in Antimicrobial Agents and Chemotherapy (01-01-2012)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
2
Emergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis
Published in Scientific reports (11-12-2022)“…Concentration dependency of phenotypic and genotypic isoniazid-rifampicin resistance emergence was investigated to obtain a mechanistic understanding on how…”
Get full text
Journal Article -
3
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid
Published in Journal of antimicrobial chemotherapy (29-05-2022)“…Abstract Objectives To develop a robust phenotypic antimicrobial susceptibility testing (AST) method with a correctly set breakpoint for pretomanid (Pa), the…”
Get full text
Journal Article -
4
Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting
Published in Journal of antimicrobial chemotherapy (12-08-2021)“…Abstract Objectives This systematic review focuses on the use of the in vitro hollow fibre infection model (HFIM) for microbial culture. We summarize the…”
Get full text
Journal Article -
5
Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution
Published in BMC microbiology (31-08-2020)“…Interest in carbapenems has been rising in the last few years due to the emergence of drug resistant tuberculosis. Ertapenem (ETP), given once a day…”
Get full text
Journal Article -
6
Role of Whole-Genome Sequencing in Characterizing the Mechanism of Action of para -Aminosalicylic Acid and Its Resistance
Published in Antimicrobial agents and chemotherapy (20-08-2020)“…-Aminosalicylic acid (PAS) remains one of the drugs of last resort for the treatment of tuberculosis, but its mechanism of action is still not completely…”
Get full text
Journal Article -
7
Glycogen synthase kinase 3 inhibition controls Mycobacterium tuberculosis infection
Published in iScience (16-08-2024)“…Compounds targeting host control of infectious diseases provide an attractive alternative to antimicrobials. A phenotypic screen of a kinase library identified…”
Get full text
Journal Article -
8
Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium Tubrculosis among Congolese patients
Published in Annals of clinical microbiology and antimicrobials (17-12-2021)“…There is paucity of data on the prevalence and distribution of multidrug- Resistant-Tuberculosis (MDR-TB) in the Republic of Congo. Among the challenges…”
Get full text
Journal Article -
9
Unveiling the complexity of rifampicin drug susceptibility testing in Mycobacterium tuberculosis : comparative analysis with next-generation sequencing
Published in Journal of medical microbiology (01-09-2024)“…The discordance between phenotypic and molecular methods of rifampicin (RIF) drug susceptibility testing (DST) in poses a significant challenge, potentially…”
Get more information
Journal Article -
10
Polymersomes Eradicating Intracellular Bacteria
Published in ACS nano (28-07-2020)“…Mononuclear phagocytes such as monocytes, tissue-specific macrophages, and dendritic cells are primary actors in both innate and adaptive immunity. These…”
Get full text
Journal Article -
11
-
12
2447. Ertapenem and Faropenem for the Treatment of Drug-Resistant Tuberculosis
Published in Open forum infectious diseases (26-11-2018)Get full text
Journal Article -
13